Sunshine Biopharma
Focus: Sunshine Biopharma is a small-molecule pharmaceutical company headquartered in Varennes, Quebec, with a portfolio heavily concentrated in generic and post-LOE drugs across cardiovascular, infectious disease, neurology, respiratory, and metabolic disease areas.
Profile data last refreshed 2h ago · AI intelligence enriched 1w ago
Open Jobs
0
About Sunshine Biopharma
AI assessmentNot HiringNo open roles listed right now. Follow Sunshine Biopharma to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
50 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
$72M (Part D)Declining
Post-LOE
Core revenue driver (77% of total) but mature generic with ongoing competitive erosion in atypical antipsychotic market.
Help build intelligence for Sunshine Biopharma
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.